Snapshot from Apr 21, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Ziyad Al-Aly
Person

Ziyad Al-Aly

Tracked across 2 events · 28 articles · First seen Mar 04, 2026 · Last active Mar 28, 2026

Sentiment
40
Attention
6
Events
2
Relationships
1
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (2)
6 60
Tech
GLP-1 Drugs Show Promise in Addiction Treatment
Ziyad Al-Aly is the lead author of the study, which provides significant evidence for the potential of GLP-1 drugs in treating substance use disorders. His research is pivotal to this medical breakthrough.
Mar 04, 2026 · 21 articles
4 20
Tech
GLP-1 Drug Discontinuation Increases Cardiovascular Risk
Ziyad Al-Aly, as the senior author of the study, gains significant recognition for his work on the long-term effects of GLP-1 drug discontinuation, highlighting his expertise in clinical epidemiology.
Mar 18, 2026 · 7 articles
Relationships (1)
Washington University in St. Louis senior author ↔ Ziyad Al-Aly Ziyad Al-Aly is the senior author of the study conducted by Washington Universit
NEWSDESK
Track Ziyad Al-Aly live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.